Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells (original) (raw)

Oncogene volume 15, pages 63–70 (1997)Cite this article

Abstract

Mutations in the tumor suppressor p53 are a common event in hepatocellular carcinoma (HCC). Because HCCs typically occur in livers with chronic injury and impaired function, we have explored the role of wild-type p53 in regulating the growth and differentiation of Hep 3B hepatoma cells, a p53-negative line derived from a liver cancer. Stable Hep 3B cell lines were generated in which inducible p53 was introduced using either a temperature-sensitive mutant (p53val135) or a tamoxifen-regulated p53-estrogen receptor chimera (p53-mERtm-pBabepuro). In both cell lines, induction of transcriptionally active p53 was confirmed by assessing several p53 targets: Mdm2 protein, p21waf1 mRNA and protein, and the cyclin G promoter. Despite marked induction of p21waf1, cells with active p53 failed to undergo growth arrest, which is probably due to the presence of a non-functional retinoblastoma protein (pRb) in these cells. Apoptosis also was not observed, even after prolonged (48 h) serum starvation or exposure to cisplatinum. Lack of apoptosis was correlated with unchanged bax mRNA levels following p53 induction. Additionally, albumin mRNA levels remained unchanged, and there was no change in basal transactivation of a reporter containing the promoter of the haptoglobin gene, encoding an acute phase protein. This suggests that growth arrest may be required to promote liver-specific gene expression. Overall, our data demonstrate that introduction of transcriptionally active p53 does not alter the malignant, dedifferentiated phenotype of Hep 3B hepatoma cells. Hence, not all cancer cells are equally responsive to the re-activation of wild-type 53. The ability of a cancer cell to undergo p53-mediated phenotypic alterations may depend on the retention of functional downstream effector pathways.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 50 print issues and online access

$259.00 per year

only $5.18 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
    S L Friedman, E Shaulian, D Resnitzky & M Oren
  2. Biochemistry of the Cell Nucleus Laboratory, Imperial Cancer Research Fund, London, UK
    T Littlewood

Authors

  1. S L Friedman
    You can also search for this author inPubMed Google Scholar
  2. E Shaulian
    You can also search for this author inPubMed Google Scholar
  3. T Littlewood
    You can also search for this author inPubMed Google Scholar
  4. D Resnitzky
    You can also search for this author inPubMed Google Scholar
  5. M Oren
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Friedman, S., Shaulian, E., Littlewood, T. et al. Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells.Oncogene 15, 63–70 (1997). https://doi.org/10.1038/sj.onc.1201149

Download citation

Keywords